nach oben

Erschienen in:

13.04.2017 | Original Article

Body composition and lung function in children with cystic fibrosis and meconium ileus

verfasst von: Artemis Doulgeraki, Argyri Petrocheilou, Glykeria Petrocheilou, George Chrousos, Stavros-Eleftherios Doudounakis, Athanasios G. Kaditis

Erschienen in: European Journal of Pediatrics | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to explore whether history of meconium ileus (MI) at birth in children and adolescents with cystic fibrosis (CF) adversely affects body composition and lung function in later life. Data of children and adolescents with CF who underwent spirometry and DXA as part of their routine care were analyzed. Associations between MI (explanatory variable) and areal bone mineral density (total body less head—TBLH aBMD), lean tissue mass (LTM), and fat mass (FM) (outcomes) were assessed using general linear models. Potential relationships of TBLH aBMD, LTM, and FM with FEV₁ (additional outcome) were also explored. One hundred and one subjects with CF (mean age 14 ± 3 years) were included, 19 (18.8%) of whom had history of MI. Negative associations were demonstrated between history of MI and FEV₁ (P = 0.04), TBLH aBMD (P = 0.03), and FM (P < 0.01) but not between history of MI and LTM (P = 0.07) after adjustment for other variables. Lung function was positively associated with TBLH aBMD (P < 0.01) and LTM (P = 0.02) but not with FM (P = 0.20).

Conclusion: Among children and adolescents with CF, those with history of MI have lower bone mineral density, FM, and lung function.

What is Known:

• Among children and adolescents with cystic fibrosis, those with history of meconium ileus in the neonatal period are at risk of having lower body mass index percentile and FEV ₁ percent predicted.

What is New:

• Children and adolescents with cystic fibrosis and history of meconium ileus have decreased bone mineral density and fat mass compared to patients without such history.

• Lower lung function in children with MI coexists with suboptimal bone mineral density.

Nur mit Berechtigung zugänglich

Shepherd RW, Holt TL, Thomas BJ, Kay L, Isles A, Francis PJ, Ward LC (1986) Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease. J Pediatr 109:788–794CrossRefPubMed

Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H, Clinical Practice Guidelines on Growth and Nutrition Subcommittee; Ad Hoc Working Group (2008) Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 108:832–839

Pedreira CC, Robert RG, Dalton V, Oliver MR, Carlin JB, Robinson P, Cameron FJ (2005) Association of body composition and lung function in children with cystic fibrosis. Pediatr Pulmonol 39:276–280CrossRefPubMed

Cystic Fibrosis Foundation Patient Registry (2014) 2013 annual data report to the center directors. Bethesda, Maryland

Buntain HM, Schluter PJ, Bell SC, Greer RM, Wong JC, Batch J, Lewindon P, Wainwright CE (2006) Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax 61:146–154CrossRefPubMed

Sheikh S, Zemel BS, Stallings VA, Rubenstein RC, Kelly A (2014) Body composition and pulmonary function in cystic fibrosis. Front Pediatr 2:33CrossRefPubMedPubMedCentral

Bianchi ML, Romano G, Saraifoger S, Costantini D, Limonta C, Colombo C (2006) BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res 21:388–396CrossRefPubMed

Williams JE, Wells JC, Benden C, Jaffe A, Suri R, Wilson CM, Fewtrell MS (2010) Body composition assessed by the 4-component model and association with lung function in 6-12-y-old children with cystic fibrosis. Am J Clin Nutr 92:1332–1343CrossRefPubMed

Evans AK, Fitzgerald DA, McKay KO (2001) The impact of meconium ileus on the clinical course of children with cystic fibrosis. Eur Respir J 18:784–789CrossRefPubMed

10.

Efrati O, Nir J, Fraser D, Cohen-Cymberknoh M, Shoseyov D, Vilozni D, Modan-Moses D, Levy R, Szeinberg A, Kerem E, Rivlin J (2010) Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study. J Pediatr Gastroenterol Nutr 50:173–178CrossRefPubMed

11.

Lai HC, Kosorok MR, Laxova A, Davis LA, Fitz Simmon SC, Farrell PM (2000) Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics 105:53–61CrossRefPubMed

12.

Dupuis A, Keenan K, Ooi CY, Dorfman R, Sontag MK, Naehrlich L, Castellani C, Strug LJ, Rommens JM, Gonska T (2016) Prevalence of meconium ileus marks the severity of mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genet Med 18:333–340CrossRefPubMed

13.

Olszowiec-Chlebna M, Koniarek-Maniecka A, Stelmach W, Smejda K, Jerzynska J, Majak P, Bialas M, Stelmach I (2016) Predictors of deterioration of lung function in Polish children with cystic fibrosis. Arch Med Sci 12:402–407CrossRefPubMedPubMedCentral

14.

Chiotis D, Krikos X, Tsiftis G, Hatzisymeaon M, Maniati-Christidi M, Dacou-Voutetaki A (2004) Body mass index and prevalence of obesity in subjects of Hellenic origin aged 0-18 years, living in the Athens area. Ann Clin Pediatr Unive Atheniensis 51:139–154

15.

Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG Jr (1993) Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 15:75–88CrossRefPubMed

16.

Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179–187CrossRefPubMed

17.

Doulgeraki A, Skarpalezou A, Theodosiadou A, Monopolis I, Schulpis K (2014) Body composition profile of young patients with phenylketonuria and mild hyperphenylalaninemia. Int J Endocrinol Metab 12:e16061CrossRefPubMedPubMedCentral

18.

Kalkwarf HJ, Abrams SA, DiMeglio LA, Koo WW, Specker BL, Weiler H; International Society for Clinical Densitometry (2014) Bone densitometry in infants and young children: the 2013 ISCD Pediatric Official Positions. J Clin Densitom 17:243–257

19.

Proesmans M, Balinska-Miskiewicz W, Dupont L, Bossuyt X, Verhaegen J, Hoiby N, de Boeck K (2006) Evaluating the “Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 27:937–943PubMed

20.

Sermet-Gaudelus I, Bianchi ML, Garabedian M, Aris RM, Morton A, Hardin DS, Elkin SL, Compston JE, Conway SP, Castanet M, Wolfe S, Haworth CS (2011) European cystic fibrosis bone mineralisation guidelines. J Cyst Fibros 10(Suppl 2):S16–S23CrossRefPubMed

21.

Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, Hosking DJ, Purdie DW, Ralston SH, Reeve J, Russell RG, Stevenson JC, Torgerson DJ (1998) A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 244:271–292CrossRefPubMed

22.

Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, Jaworski M, Gordon CM; International Society for Clinical Densitometry (2014) Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom 17:225–242

23.

Putman MS, Baker JF, Uluer A, Herlyn K, Lapey A, Sicilian L, Tillotson AP, Gordon CM, Merkel PA, Finkelstein JS (2015) Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period. J Cyst Fibros 14:526–532CrossRefPubMedPubMedCentral

24.

Lucidi V, Alghisi F, Raia V, Russo B, Valmarana L, Valmarana R, Coruzzo A, Beschi S, Dester S, Rinaldi D, Maglieri M, Guidotti ML, Ravaioli E, Pesola M, De Alessandri A, Padoan R, Grynzich L, Ratclif L, Repetto T, Ambroni M, Provenzano E, Tozzi AE, Colombo C (2009) Growth assessment of paediatric patients with CF comparing different auxologic indicators: a multicentre Italian study. J Pediatr Gastroenterol Nutr 49:335–342CrossRefPubMed

25.

Baker JF, Putman MS, Herlyn K, Tillotson AP, Finkelstein JS, Merkel PA (2016) Body composition, lung function, and prevalent and progressive bone deficits among adults with cystic fibrosis. Joint Bone Spine 83:207–211CrossRefPubMed

26.

Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H, Drevinek P, Gulmans V, Krivec U, Olesen H, Group EPRS (2014) Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. Eur Respir J 43:125–133CrossRefPubMed

27.

Carlyle BE, Borowitz DS, Glick PL (2012) A review of pathophysiology and management of fetuses and neonates with meconium ileus for the pediatric surgeon. J Pediatr Surg 47:772–781CrossRefPubMed

28.

Li Z, Lai HJ, Kosorok MR, Laxova A, Rock MJ, Splaingard ML, Farrell PM (2004) Longitudinal pulmonary status of cystic fibrosis children with meconium ileus. Pediatr Pulmonol 38:277–284CrossRefPubMed

29.

Kappler M, Feilcke M, Schroter C, Kraxner A, Griese M (2009) Long-term pulmonary outcome after meconium ileus in cystic fibrosis. Pediatr Pulmonol 44:1201–1206CrossRefPubMed

30.

Johnson JA, Bush A, Buchdahl R (2010) Does presenting with meconium ileus affect the prognosis of children with cystic fibrosis? Pediatr Pulmonol 45:951–958CrossRefPubMed

31.

Kerem E, Corey M, Kerem B, Durie P, Tsui LC, Levison H (1989) Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr 114:767–773CrossRefPubMed

32.

Coutts JA, Docherty JG, Carachi R, Evans TJ (1997) Clinical course of patients with cystic fibrosis presenting with meconium ileus. Br J Surg 84:555CrossRefPubMed

33.

Vanacor R, Raimundo FV, Marcondes NA, Corte BP, Ascoli AM, Azambuja AZ, Scopel L, Santos PV, Dalcin PT, Faulhaber GA, Furlanetto TW (2014) Prevalence of low bone mineral density in adolescents and adults with cystic fibrosis. Rev Assoc Med Bras (1992) 60:53–58CrossRef

34.

Street ME, Spaggiari C, Ziveri MA, Volta C, Federico G, Baroncelli GI, Bernasconi S, Saggese G (2006) Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines. Horm Res 66:162–168PubMed

35.

Frangolias DD, Pare PD, Kendler DL, Davidson AG, Wong L, Raboud J, Wilcox PG (2003) Role of exercise and nutrition status on bone mineral density in cystic fibrosis. J Cyst Fibros 2:163–170CrossRefPubMed

36.

Dassios T, Kaditis A, Katelari A, Chrousos G, Doudounakis S, Dimitriou G (2015) Time constant of inspiratory muscle relaxation in cystic fibrosis. Pediatr Res 77:541–545CrossRefPubMed

37.

Dassios TG, Katelari A, Doudounakis S, Dimitriou G (2014) Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis. Respir Care 59:363–370CrossRefPubMed

Titel: Body composition and lung function in children with cystic fibrosis and meconium ileus
verfasst von: Artemis Doulgeraki
Argyri Petrocheilou
Glykeria Petrocheilou
George Chrousos
Stavros-Eleftherios Doudounakis
Athanasios G. Kaditis
Publikationsdatum: 13.04.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Pediatrics / Ausgabe 6/2017
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-017-2906-z

Neu im Fachgebiet Pädiatrie

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO₂. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Body composition and lung function in children with cystic fibrosis and meconium ileus

Abstract

Neu im Fachgebiet Pädiatrie

Klimaschutz beginnt bei der Wahl des Inhalators

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Pädiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

A risk score based on admission characteristics to predict progressive hemorrhagic injury from traumatic brain injury in children

Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands

Development, prevention, and treatment of feeding tube dependency

A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR

Erratum to: Validation of the custo screen pediatric blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010

Evidence of a link between fever and microscopic hematuria in children

Neu im Fachgebiet Pädiatrie

Klimaschutz beginnt bei der Wahl des Inhalators

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Pädiatrie